FDNA to Launch Online “Unknown Forum” for Undiagnosed and Challenging Cases at ACMG 2015

March 12, 2015

Face2Gene® is a search and reference tool powered by the Facial Dysmorphology Novel Analysis Technology

New York, NY (PRNewswire) March 12, 2015  – “FDNA, the pioneer in computer-aided dysmorphology analysis, has announced today the launch of an online forum for the genetics expert community dedicated to the discussion and review of undiagnosed and challenging cases. The company will unveil the online forum in a scheduled theater presentation at the Annual Clinical Genetics Meeting ACMG 2015 in Salt Lake City, UT on March 26th, 2015 at 11:40 am.

Face2Gene facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date genetic references. One of the unmet needs raised by Face2Gene users worldwide is the need to consult with their peers in the genetics community about certain cases. Some of the cases they encounter have genetic syndromes that are so rare, that only the cumulative knowledge and experience of the larger geneticist community can lead to a diagnosis.”

Read More

Share this article

Most popular news

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading